TB-500 / BPC-157 Blend

The TB-500 / BPC-157 Blend combines two experimental peptides commonly studied in preclinical models of tissue response and repair signaling. TB-500 is associated with the actin-binding region of thymosin beta-4 and is investigated in cell migration and cytoskeletal pathways, while BPC-157 has been examined in models involving fibroblasts, angiogenic signaling, nitric-oxide regulation and tissue integrity. The blend may support multi-pathway studies, but evidence for the combination is less developed than the literature on each component separately. Researchers should include single-component controls, verify the ratio and exact sequence of both materials, and avoid assuming additive or synergistic effects without direct experimental evidence.

For laboratory research use only. Not for human or veterinary use. This description is informational and does not provide medical advice, dosing, or treatment guidance.